ArticleClinical rheumatology2025

Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.